Syringin: a naturally occurring compound with medicinal properties
- PMID: 39104400
- PMCID: PMC11298447
- DOI: 10.3389/fphar.2024.1435524
Syringin: a naturally occurring compound with medicinal properties
Abstract
Syringin, a phenylpropanoid glycoside, is widely distributed in various plants, such as Acanthopanax senticosus (Rupr. et Maxim.) Harms, Syringa reticulata (BL) Hara var. mandshurica (Maxim.) Hara, and Ilex rotunda Thumb. It serves as the main ingredient in numerous listed medicines, health products, and foods with immunomodulatory, anti-tumor, antihyperglycemic, and antihyperlipidemic effects. This review aims to systematically summarize syringin, including its physicochemical properties, plant sources, extraction and separation methods, total synthesis approaches, pharmacological activities, drug safety profiles, and preparations and applications. It will also cover the pharmacokinetics of syringin, followed by suggestions for future application prospects. The information on syringin was obtained from internationally recognized scientific databases through the Internet (PubMed, CNKI, Google Scholar, Baidu Scholar, Web of Science, Medline Plus, ACS Elsevier, and Flora of China) and libraries. Syringin, extraction and separation, pharmacological activities, preparations and applications, and pharmacokinetics were chosen as the keywords. According to statistics, syringin can be found in 23 families more than 60 genera, and over 100 species of plants. As a key component in many Chinese herbal medicines, syringin holds significant research value due to its unique sinapyl alcohol structure. Its diverse pharmacological effects include immunomodulatory activity, tumor suppression, hypoglycemic action, and hypolipidemic effects. Additionally, it has been shown to provide neuroprotection, liver protection, radiation protection, cardioprotection, and bone protection. Related preparations such as Aidi injection, compound cantharidin capsule, and Tanreqing injection have been widely used in clinical settings. Other studies on syringin such as extraction and isolation, total synthesis, safety profile assessment, and pharmacokinetics have also made progress. It is crucial for medical research to deeply explore its mechanism of action, especially regarding immunity and tumor therapy. Meanwhile, more robust support is needed to improve the utilization of plant resources and to develop extraction means adapted to the needs of industrial biochemistry to further promote economic development while protecting people's health.
Keywords: extraction and separation; pharmacokinetics; pharmacological activities; preparations and applications; syringin.
Copyright © 2024 Qian, Pan, Yang, Wang, Luo, Wu, Ma, Wang, Li and Gao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
A systematic review: Botany, phytochemistry, traditional uses, pharmacology, toxicology, quality control and pharmacokinetics of Ilex rotunda Thunb.J Ethnopharmacol. 2022 Nov 15;298:115419. doi: 10.1016/j.jep.2022.115419. Epub 2022 Jun 30. J Ethnopharmacol. 2022. PMID: 35781006 Review.
-
Aralia elata var. mandshurica (Rupr. & Maxim.) J.Wen: An overview of pharmacological studies.Phytomedicine. 2016 Nov 15;23(12):1409-1421. doi: 10.1016/j.phymed.2016.07.011. Epub 2016 Aug 3. Phytomedicine. 2016. PMID: 27765361 Review.
-
Gardenia jasminoides Ellis: Ethnopharmacology, phytochemistry, and pharmacological and industrial applications of an important traditional Chinese medicine.J Ethnopharmacol. 2020 Jul 15;257:112829. doi: 10.1016/j.jep.2020.112829. Epub 2020 Apr 18. J Ethnopharmacol. 2020. PMID: 32311486 Review.
-
Syringin prevents bone loss in ovariectomized mice via TRAF6 mediated inhibition of NF-κB and stimulation of PI3K/AKT.Phytomedicine. 2018 Mar 15;42:43-50. doi: 10.1016/j.phymed.2018.03.020. Epub 2018 Mar 12. Phytomedicine. 2018. PMID: 29655696
-
Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways.J Transl Med. 2022 Jul 6;20(1):310. doi: 10.1186/s12967-022-03504-6. J Transl Med. 2022. PMID: 35794555 Free PMC article.
References
-
- Ahmed S., Moni D. A., Sonawane K. D., Paek K. Y., Shohael A. M. (2021). A comprehensive in silico exploration of pharmacological properties, bioactivities and COX-2 inhibitory potential of eleutheroside B from Eleutherococcus senticosus (Rupr. and Maxim.) Maxim. J. Biomol. Struct. Dyn. 39, 6553–6566. 10.1080/07391102.2020.1803135 - DOI - PubMed
-
- Aventurado C. A., Castillo A. L., Vasquez R. D. (2023). Syringin as TGF-βR1, HER2, EGFR, FGFR4 Kinase, and MMP-2 inhibitor and potential cytotoxic agent against ER+ Breast cancer cells. Curr. Enzyme Inhib. 19, 55–64. 10.2174/1573408019666221107145705 - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials